Previous issue | Volume 92 | ESPE2019 | Next issue

58th Annual ESPE

Vienna, Austria
19 Sep 2019 - 21 Sep 2019

Card image cap
The theme of this year’s meeting is Variety and Variation in Paediatric Endocrinology. Join us in Vienna to explore the diversity we encounter in our discipline and the care that we have to exercise when using the term “normality”. Whilst gaining an update on the latest treatments, clinical best practice and cutting edge research in the field of paediatric endocrinology.

Symposia

ISPAD/Complications of Type 1 Diabetes

hrp0092s4.1 | ISPAD/Complications of Type 1 Diabetes | ESPE2019

Hypoglycemia in Children with T1D: Past, Present, and Future

Maahs David

Among the many complications of type 1 diabetes (T1D), hypoglycemia is an acute concern for children with T1D and their families. Moreover, fear of hypoglycemia is a common barrier to achieving glucose targets. Numerous advances in care have been made since the Diabetes Control and Complications Trial was published in 1993 in which lower HbA1c was associated with increasing risk of severe hypoglycemia. More recent data indicate that lower HbA1c (7% ISPAD target) can be ach...

hrp0092s4.2 | ISPAD/Complications of Type 1 Diabetes | ESPE2019

Novel Advances in Diabetic Retinopathy Screening and Management

Donaghue Kim

Screening for diabetic retinopathy has been expanded from ophthalmology-based assessments. Retinal photography can be used in primary care by trained photographers, and then graded by trained staff using Telemedicine. Ultrawide retinal cameras can now capture over 80% of the retina from a single image. It may be more predictive of progression to proliferative retinopathy than the traditional views, but cost of equipment for benefit is unclear. There have been advances in D...

hrp0092s4.3 | ISPAD/Complications of Type 1 Diabetes | ESPE2019

Prediction of Renal and Cardiovascular Complications

Marcovecchio Loredana

Vascular complications continue to be a major concern for young people with type 1 diabetes (T1D), who have a decreased life expectancy, by 8-16 years, compared to the background population. Diabetic nephropathy and cardiovascular disease are main contributors to morbidity and mortality in people with T1D. Thus, early detection and prevention of complications are of paramount importance to improve their long-term prognosis.Although HbA1c is a major risk ...